Abstract
A neophroblastoma-inducing myeloblastosis-associated virus, MAV-2(N), derived from avian myeloblastosis virus was characterized with respect to biochemical composition and avian pathogenesis. Purified fibroblast-grown virus contained the same size 35S ribonucleic acid and the same relative amounts of viral polypeptides as another myeloblastosis-associated virus inducing predominantly osteopetrosis MAV-2(O). Plaque-purified MAV-2(N) induced a 76 to 93% incidence of nephroblastoma and a 3 to 50% incidence of osteopetrosis in SPAFAS and line 15 x 7 chickens: the oncogenic spectrum and the onset of nephroblastoma varied with the line of chicken and the route of injection. Renal neoplasms were manifest in chickens older than 2 months and grew to a massive size. Furthermore, 29% of control chickens housed with MAV-2(N)-infected chickens demonstrated nephroblastoma. MAV-2(N)-infected chickens had growth rates and blood packed cell volumes comparable to those of uninfected chickens. Infected chickens 2 months of age had increased kidney, liver, and spleen weights; tumor-bearing chickens 3 to 4 months of age had increased liver, lung, brain, pancreas, and bone weights. The concentration of albumin was decreased and the concentration of gamma globulin was increased in the serum of MAV-2(N)-INFECTED CHICKENS. Analysis of the sera of nephroblastoma-bearing chickens for virus and antibody showed that three states existed: (i) high levels of neutralizing antibody, (ii) high levels of virus, and (iii) simultaneous presence of both at low levels. The pathological and virological features of MAV-2(N) which distinguish it from MAV-2(O) are discussed.
Collapse